Sleeve Gastrectomy Versus Banded Roux-en-Y Gastric Bypass for Obesity and Diabetes Mellitus: Psychology and Quality of Life Outcomes at 10 Years - Scorecard - MDSpire
Advertisement
Sleeve Gastrectomy Versus Banded Roux-en-Y Gastric Bypass for Obesity and Diabetes Mellitus: Psychology and Quality of Life Outcomes at 10 Years
Clinical Scorecard: Comparative Analysis of Sleeve Gastrectomy and Banded Roux-en-Y Gastric Bypass on Psychological Well-being and Quality of Life in Obese Patients with Diabetes After a Decade
At a Glance
Category
Detail
Condition
Obesity with Type 2 Diabetes Mellitus (T2DM)
Key Mechanisms
Metabolic bariatric surgery (MBS) including Sleeve Gastrectomy (SG) and silastic-ring Roux-en-Y gastric bypass (SR-RYGB) impact psychological health and quality of life (QOL) through weight loss and resolution of obesity-related complications, but may also cause adverse psychosocial effects.
Target Population
Adults aged 20–55 years with BMI 35–65 kg/m2 and T2DM diagnosed at least 6 months prior, suitable for SG or SR-RYGB.
Care Setting
Single bariatric center in New Zealand; multidisciplinary preoperative assessment and surgical intervention.
Key Highlights
Both SG and SR-RYGB improve depressive and anxiety symptoms significantly within the first year post-surgery.
At 5 years, depressive symptoms remain improved but anxiety symptoms return to baseline; 10-year outcomes focus on long-term psychological health and QOL.
SR-RYGB with silastic ring shows greater weight loss and limited weight regain compared to SG, potentially influencing psychological and QOL outcomes.
Guideline-Based Recommendations
Diagnosis
Use Hospital Anxiety and Depression Scale (HADS) for screening depressive and anxiety symptoms pre- and post-MBS.
Assess quality of life using validated tools such as RAND-36 questionnaire covering physical and emotional health domains.
Management
Perform preoperative psychological screening as recommended by International Federation for Surgery of Obesity (IFSO) to optimize psychosocial factors.
Select type of MBS (SG vs SR-RYGB) considering patient-centered outcomes including psychological health and QOL.
Reserve public funding for MBS to patients likely to derive maximal benefit based on comprehensive assessment.
Monitoring & Follow-up
Long-term follow-up (up to 10 years) of psychological symptoms and QOL using standardized questionnaires.
Monitor for postoperative complications and psychosocial implications that may negatively impact psychological health.
Risks
Potential adverse outcomes of MBS include altered gastrointestinal function and psychosocial effects that may worsen psychological health and QOL.
Overlap of psychological symptoms with postoperative changes (e.g., appetite, bowel habits) requires careful interpretation.
Patient & Prescribing Data
Obese adults with T2DM undergoing SG or SR-RYGB.
Both surgical options improve psychological symptoms initially; SR-RYGB may offer superior long-term weight loss and sustained QOL benefits, but anxiety symptoms may return to baseline by 5 years.
Clinical Best Practices
Incorporate multidisciplinary preoperative education and psychological assessment to optimize patient readiness for MBS.
Use validated tools (HADS, RAND-36) for standardized assessment of psychological health and QOL pre- and postoperatively.
Consider long-term psychological and QOL outcomes when selecting MBS type for patients with obesity and T2DM.
Maintain extended follow-up beyond 5 years to monitor and address evolving psychological and quality of life issues.
A four-factor staging system stratified response rates from 90.9% to 37.5% in a retrospective cohort study, although the model showed only moderate discrimination (C statistic, 0.68) and requires external validation
